Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$317.7M
+21.8% from 2023
Prescriptions
72K
$4,400.11 per claim
Patients
9,054
5,777 prescribers
Total spending, 2024
$317.9M
$35,081.38 per patient
Medicare prescription drug plans paid $317.7M for Nucala in 2024, for 72,210 prescriptions and refills to 9,054 patients (up 21.8% from 2023). The average cost per claim was $4,400.11.
New York had the highest Medicare cost for Nucala in 2024: $29.0M for 6,270 claims, followed by California ($25.1M).
Anne Marie Holly, physician assistant in Rochester, NY, had the highest Medicare cost for Nucala in 2024: 179 claims costing $1.1M.
Nucala is made by GSK plc (GSK), listed in the Medicare spending data as Glaxosmithkline.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Anne Marie Holly Rochester, NY | Physician Assistant | 179 | 36 | $1.1M |
| Alec J Steils Waterloo, IA | Nurse Practitioner | 203 | 20 | $912K |
| Vivek S Sambhara |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 4,248 | 47,961 | 6,359 | $193.3M |
| 2023 | 4,950 | 59,018 | 7,614 | $260.9M |
| 2024 | 5,777 | 72,210 | 9,054 | $317.7M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 187 |
| 20 |
| $779K |
| Wilfredo A Villarrubia West Columbia, SC | Physician Assistant | 117 | 29 | $716K |
| James G Lampasso Williamsville, NY | Pulmonary Disease | 179 | 21 | $691K |
| Frances E Lee Atlanta, GA | Pulmonary Disease | 103 | 14 | $622K |
| Praveen Akuthota San Diego, CA | Critical Care (Intensivists) | 64 | Under 11 | $610K |
| Luz J Barahona Kinston, NC | Internal Medicine | 128 | 14 | $609K |
| Matthew P Varner Columbia, SC | Pulmonary Disease | 169 | 18 | $605K |
| Rebecca B Ezell Slidell, LA | Nurse Practitioner | 157 | 20 | $577K |
| 1407808033 | Pulmonary Disease | 64 | Under 11 | $576K |
| Janiece A Feuerstein Grand Rapids, MI | Nurse Practitioner | 153 | 23 | $563K |
| Yousof E Elgaried Pikeville, KY | Pulmonary Disease | 145 | 16 | $557K |
| Jitendrakumar S Gupta Sioux City, IA | Pulmonary Disease | 143 | 17 | $523K |
| Tapas Bandyopadhyay West Hartford, CT | Pulmonary Disease | 126 | 12 | $509K |
| Geoffrey L Chupp New Haven, CT | Pulmonary Disease | 63 | Under 11 | $480K |
| Dennis M Dale Slidell, LA | Pulmonary Disease | 120 | 17 | $463K |
| Christopher Faber Pittsburgh, PA | Pulmonary Disease | 124 | 16 | $460K |
| Charles A Thompson Anderson, SC | Pulmonary Disease | 103 | 18 | $451K |
| Pooja Bhadbhade Kansas City, KS | Rheumatology | 52 | Under 11 | $448K |
| Sarah J Hayat Lawrenceville, GA | Internal Medicine | 111 | 15 | $439K |
| Cassie Kaufman Springdale, AR | Physician Assistant | 62 | Under 11 | $437K |
| Richard W Rissmiller Jr. Charleston, SC | Pulmonary Disease | 90 | 13 | $428K |
| Tiffany Peraino Riverside, CA | Physician Assistant | 71 | Under 11 | $428K |
| Shyamsunder Subramanian Tracy, CA | Pulmonary Disease | 116 | 17 | $423K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Glaxosmithkline GSK | 72,258 | $317.9M |